trial

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

NCTId NCT06546475
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Not Yet Recruiting
Enrollment 20 (estimated)
Sponsored by National Taiwan University Hospital
Primary completion 2027-07-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Not Yet Recruiting
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2024-08-01
Primary completion
2027-07-31
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
N-acetylcysteine

Sponsors

National Taiwan University HospitalLead Sponsor

Investigators

1
Chen-Chung Liu, MD, PhDPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
20
Phase
PHASE4
Primary Completion Date
2027-07-31
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
N-acetylcysteine
drug
lead_sponsor
National Taiwan University Hospital
company
indication
Schizophrenia
indication
Psychosis
indication
Recurrence
indication
investigator
Chen-Chung Liu, MD, PhD
person